Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,572,826
+$747,919 QoQ
Shares Held
87,574
+47.6% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 207 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. AMLX ranks #24 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 893,500 $64,206,902
2 NBIX
Neurocrine Biosciences Inc
 329,065 $55,460,607
3 VTRS
Viatris Inc
 3,423,675 $54,367,956
4 UTHR
UNITED THERAPEUTICS Corp
 61,355 $33,243,974
5 ELAN
Elanco Animal Health Inc
 1,112,894 $27,388,318
6 LNTH
Lantheus Holdings, Inc.
 147,146 $16,324,370
7 TEVA
Teva Pharmaceutical Industries Ltd
 427,444 $14,481,798
8 ALKS
Alkermes plc.
 222,624 $11,665,496

All Filings in AMLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,572,826 87,574
2026-03-31 $824,907 59,346
2025-12-31 $790,489 65,438
2025-09-30 $752,964 55,406
2025-06-30 $39,927 6,229
2025-03-31 $23,718 6,700
2024-12-31 $19,160 5,069
2024-09-30 $22,644 6,989
2024-06-30 $17,326 9,119
2024-03-31 $460 162
2023-12-31 $41,760 2,837
2023-09-30 $82,083 4,483
2023-06-30 $4,184 194
2023-03-31 $938 32